Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and tolerability of AB154 in adults with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AB154

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Solid Tumor, Unspecified, Adult | Phase 1 | Status: COMPLETED